BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22699442)

  • 1. Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.
    Amuguni H; Tzipori S
    Hum Vaccin Immunother; 2012 Jul; 8(7):979-86. PubMed ID: 22699442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
    Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.
    Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S
    Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus subtilis spore with surface display of paramyosin from Clonorchis sinensis potentializes a promising oral vaccine candidate.
    Sun H; Lin Z; Zhao L; Chen T; Shang M; Jiang H; Tang Z; Zhou X; Shi M; Zhou L; Ren P; Qu H; Lin J; Li X; Xu J; Huang Y; Yu X
    Parasit Vectors; 2018 Mar; 11(1):156. PubMed ID: 29514667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.
    Lee S; Belitsky BR; Brown DW; Brinker JP; Kerstein KO; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2010 Sep; 28(41):6658-65. PubMed ID: 20709005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Bacillus subtilis spores for the delivery of Mycobacterium tuberculosis Ag85B-CFP10 secretory antigens.
    Das K; Thomas T; Garnica O; Dhandayuthapani S
    Tuberculosis (Edinb); 2016 Dec; 101S():S18-S27. PubMed ID: 27727129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner.
    Mauriello EM; Duc le H; Isticato R; Cangiano G; Hong HA; De Felice M; Ricca E; Cutting SM
    Vaccine; 2004 Mar; 22(9-10):1177-87. PubMed ID: 15003646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery.
    Paccez JD; Luiz WB; Sbrogio-Almeida ME; Ferreira RC; Schumann W; Ferreira LC
    Vaccine; 2006 Apr; 24(15):2935-43. PubMed ID: 16503367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A probiotic treatment increases the immune response induced by the nasal delivery of spore-adsorbed TTFC.
    Santos FDS; Mazzoli A; Maia AR; Saggese A; Isticato R; Leite F; Iossa S; Ricca E; Baccigalupi L
    Microb Cell Fact; 2020 Feb; 19(1):42. PubMed ID: 32075660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface display of recombinant proteins on Bacillus subtilis spores.
    Isticato R; Cangiano G; Tran HT; Ciabattini A; Medaglini D; Oggioni MR; De Felice M; Pozzi G; Ricca E
    J Bacteriol; 2001 Nov; 183(21):6294-301. PubMed ID: 11591673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae.
    Wang Y; Wang J; Zhou M; Liu P; Zhang E; Li Y; Lin J; Feng Z; Yang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31492763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores.
    Zhou Z; Gong S; Li XM; Yang Y; Guan R; Zhou S; Yao S; Xie Y; Ou Z; Zhao J; Liu Z
    J Med Microbiol; 2015 Jan; 64(Pt 1):104-110. PubMed ID: 25355934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit.
    Hu B; Li C; Lu H; Zhu Z; Du S; Ye M; Tan L; Ren D; Han J; Kan S; Wang J; Jin N
    J Virol Methods; 2011 Jan; 171(1):272-9. PubMed ID: 21129406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.
    Grangette C; Müller-Alouf H; Goudercourt D; Geoffroy MC; Turneer M; Mercenier A
    Infect Immun; 2001 Mar; 69(3):1547-53. PubMed ID: 11179325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunological characteristics and probiotic function of recombinant Bacillus subtilis spore expressing Clonorchis sinensis cysteine protease.
    Tang Z; Shang M; Chen T; Ren P; Sun H; Qu H; Lin Z; Zhou L; Yu J; Jiang H; Zhou X; Li X; Huang Y; Xu J; Yu X
    Parasit Vectors; 2016 Dec; 9(1):648. PubMed ID: 27993173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine.
    Zhao G; Miao Y; Guo Y; Qiu H; Sun S; Kou Z; Yu H; Li J; Chen Y; Jiang S; Du L; Zhou Y
    Hum Vaccin Immunother; 2014; 10(12):3649-58. PubMed ID: 25483702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model.
    Sibley L; Reljic R; Radford DS; Huang JM; Hong HA; Cranenburgh RM; Cutting SM
    FEMS Microbiol Lett; 2014 Sep; 358(2):170-9. PubMed ID: 24990572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal vaccine delivery by non-recombinant spores of Bacillus subtilis.
    Ricca E; Baccigalupi L; Cangiano G; De Felice M; Isticato R
    Microb Cell Fact; 2014 Aug; 13():115. PubMed ID: 25112405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial Spore-Based Delivery System: 20 Years of a Versatile Approach for Innovative Vaccines.
    Isticato R
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of recombinant and non-recombinant Bacillus subtilis spore display technology for presentation of antigen and adjuvant on single spore.
    Potocki W; Negri A; Peszyńska-Sularz G; Hinc K; Obuchowski M; Iwanicki A
    Microb Cell Fact; 2017 Sep; 16(1):151. PubMed ID: 28899372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.